These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22426961)

  • 1. Effect of shRNA targeting survivin on ovarian cancer.
    Xing J; Jia CR; Wang Y; Guo J; Cai Y
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1221-9. PubMed ID: 22426961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].
    Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
    Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
    Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
    Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
    Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Chen WX; Chen Y; He H
    Ai Zheng; 2005 Aug; 24(8):945-50. PubMed ID: 16086871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
    Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
    Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
    Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of human epidermal growth factor receptor-2 siRNA on chemosensitivity to cisplatin of human ovarian carcinoma cells: an in vitro experiment].
    Lu YM; Zhang SL; Meng LR; Zhao YY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):909-13. PubMed ID: 18756958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
    Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
    Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM].
    Deng KX; Zhong L; Jiang MX; Wang PL; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):836-9. PubMed ID: 16412331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of reduced expression of Her2 by RNA interference on the biological characters of ovarian carcinoma cells].
    Wang KF; Cui H; Feng J; Yang R; Liang XD; Chang XH; Li Y; Cheng YX; Cheng HY; Ye X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):622-5. PubMed ID: 19087501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
    Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
    J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells.
    Zhang Y; Chang S; Sun J; Zhu S; Pu C; Li Y; Zhu Y; Wang Z; Xu RX
    Mol Pharm; 2015 Sep; 12(9):3137-45. PubMed ID: 26212628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of antisense survivin RNA transfection on the growth of ovarian carcinoma SKOV3 cells in vitro and in vivo].
    Shi HR; Lan L; Qiao YH; Li KH; Hou LJ; Liu HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):831-5. PubMed ID: 16412330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
    Zhang K; Li Y; Liu W; Gao X; Zhang K
    Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo.
    Wen LJ; Gao LF; Jin CS; Zhang HJ; Ji K; Yang JP; Zhao XJ; Wen MJ; Guan GF
    Int J Clin Exp Pathol; 2013; 6(10):2071-81. PubMed ID: 24133585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly.
    Hu Q; Li W; Hu X; Hu Q; Shen J; Jin X; Zhou J; Tang G; Chu PK
    Biomaterials; 2012 Sep; 33(27):6580-91. PubMed ID: 22717365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
    Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
    Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.